Advancement of deep learning models with whole slide image in diagnosis, subtyping and prognosis for glioma.

Gliomas are heterogeneous primary central nervous system (CNS) tumors with diverse molecular subtypes and variable prognosis. A paradigm shift in histopathology is underway as samples are digitized into whole-slide images (WSIs). Deep learning (DL) shows great potential for glioma diagnosis, subtyping, grading, and prognosis. This review summarizes recent advances in WSI-based DL models, covering data preprocessing, model architectures, and translational performance. Model evolution has progressed from CNNs (e.g., ResNet, capturing local features via convolution) to Transformers (e.g., Vision transformer, modeling global dependencies via self‑attention), hybrid architectures, and large language model (LLM). Typical pipelines include quality control, stain normalization, patch extraction, feature integration, and prediction. Public datasets such as TCGA and CPTAC serve as key resources. On various datasets (public and institutional), a glioma‑specific model ResNet‑50 achieved AUC 0.983 for subtype classification; a Vision Transformer model reached AUC 0.960 for molecular typing; a hybrid model, ROAM, attained AUC 0.990; and the pan‑cancer hybrid model called CHIEF achieved AUC 0.9397 for diagnosis. Attention heatmaps and Shapley Additive exPlanations (SHAP) provide interpretability by linking model outputs to histologic regions. Novel multimodal fusion integrates genomic, proteomic, radiologic, and clinical data to enhance prediction and uncover biological relevance. Future research may focus on enhancing model generalizability and predictive accuracy via advanced architectures, developing lightweight models for resource-limited settings to facilitate clinical translation. .